ClinicalTrials.Veeva

Menu

Early Surgery for Patients With Asymptomatic Aortic Stenosis (ESTIMATE)

A

Assistance Publique - Hôpitaux de Paris

Status

Unknown

Conditions

Aortic Valve Stenosis
Aortic Valve Surgery

Treatments

Other: Delayed Surgical aortic valve replacement
Other: Early surgical aortic valve replacement

Study type

Interventional

Funder types

Other

Identifiers

NCT02627391
AOM 140460

Details and patient eligibility

About

Many cardiologists are convinced that early surgery in asymptomatic aortic stenosis (AS) saves lives. However there is currently no direct evidence for this and most recommendations from the ESC/ EACTS or ACC/ AHA in this field are supported by Level-B or C evidence. Therefore, the investigators designed a randomized controlled trial to demonstrate whether early surgery improves mortality and morbidity of patients with asymptomatic severe AS and low operative risk.

Enrollment

360 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria

  • Adult patient, aged between 18 and 80 years (18 ≤ age ≤80)
  • Low operative risk, defined as EuroSCORE II ≤ 5%
  • No symptom potentially attributable to AS: no dyspnea, angina or syncope during exercise
  • No class I indication for surgery
  • No symptom/ fall in blood pressure during exercise test
  • Severe AS according to current echocardiography criteria: Vmax > 4.0 m/s and/ or MPG > 40 mm Hg); AVA < 1.0 cm2 (not mandatory)
  • Preserved LV systolic function: LVEF >50% according to echocardiography ; no LV wall motion abnormality
  • Signed informed consent

Exclusion criteria

  • Moderate/ high operative risk for aortic valve replacement, defined as EuroSCORE II > 5%
  • Class-I indication for AVR (ESC-EACTS 2012, ACC/ AHA 2014) or fall in blood pressure during exercise testing (Class-IIa)
  • Other indication for cardiac surgery (CABG, thoracic aorta)
  • Positive exercise test including A/ unmasking of symptoms (angina, dyspnea at low workload, dizziness or syncope) during exercise or B/ Fall in systolic blood pressure during exercise below the baseline value.
  • Patients unable to perform the exercise ECG
  • More than mild AR (>grade 2/4)/ other significant valve disease LVEF ≤ 50%
  • Serum creatinine >160 μmol/L
  • Serious extra cardiac comorbidity/ life expectancy <2 years
  • Patient included in another trial with signed informed consent
  • Patient not affiliated to social insurance
  • Pregnancy

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

360 participants in 2 patient groups

Early surgery
Experimental group
Description:
Surgical aortic valve replacement
Treatment:
Other: Early surgical aortic valve replacement
Delayed surgery according to guidelines
Active Comparator group
Description:
Surgical aortic valve replacement
Treatment:
Other: Delayed Surgical aortic valve replacement

Trial contacts and locations

1

Loading...

Central trial contact

Jean-Luc MONIN, MD PhD.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems